Eagle Pharmaceuticals, Inc.

BARCLAYS PLC EGRX
Report date
12/31/2024
Quarter
2024 Q4
Filed
3/19/2026
Shares
14,233
Value ($000)
7
Weight
0.0%
2014 Q1 - 2024 Q4 (22 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).